Related Experiment Video
Updated: Jan 20, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Abstract:
According to results from a phase I/II trial, the investigational WEE1 inhibitor adavosertib combined with gemcitabine and radiation is well tolerated and may benefit patients with locally advanced pancreatic adenocarcinoma by increasing both systemic and local disease control.
Related Concept Videos
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:17An Orthotopic Resectional Mouse Model of Pancreatic Cancer
11:44Isolation of Stem Cells from Human Pancreatic Cancer Xenografts
09:25Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
10:04Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
07:31Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

